Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_178425.4(HDAC9):c.368G>C(p.Arg123Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000894 in 1,454,230 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
HDAC9 (HGNC:14065): (histone deacetylase 9) Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene has sequence homology to members of the histone deacetylase family. This gene is orthologous to the Xenopus and mouse MITR genes. The MITR protein lacks the histone deacetylase catalytic domain. It represses MEF2 activity through recruitment of multicomponent corepressor complexes that include CtBP and HDACs. This encoded protein may play a role in hematopoiesis. Multiple alternatively spliced transcripts have been described for this gene but the full-length nature of some of them has not been determined. [provided by RefSeq, Jul 2008]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.368G>C (p.R123T) alteration is located in exon 3 (coding exon 3) of the HDAC9 gene. This alteration results from a G to C substitution at nucleotide position 368, causing the arginine (R) at amino acid position 123 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
.;.;.;.;Gain of phosphorylation at R120 (P = 0.014);Gain of phosphorylation at R120 (P = 0.014);Gain of phosphorylation at R120 (P = 0.014);.;.;Gain of phosphorylation at R120 (P = 0.014);.;.;.;.;